These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21401869)

  • 21. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
    Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
    Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion.
    Kreisel D; Krupnick AS; Balsara KR; Riha M; Gelman AE; Popma SH; Szeto WY; Turka LA; Rosengard BR
    J Immunol; 2002 Dec; 169(11):6154-61. PubMed ID: 12444119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
    J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance.
    Zhao X; Boenisch O; Yeung M; Mfarrej B; Yang S; Turka LA; Sayegh MH; Iacomini J; Yuan X
    Am J Transplant; 2012 Jan; 12(1):90-101. PubMed ID: 21992708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
    Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
    J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
    Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
    Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
    Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
    J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
    Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
    J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
    Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
    Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
    Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
    J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.